相似文献
1
Assessing the risk of second malignancies after modern radiotherapy.
Nat Rev Cancer. 2011 Jun;11(6):438-48. doi: 10.1038/nrc3069. Epub 2011 May 19.
2
The effect of radiation quality on the risks of second malignancies.
Int J Radiat Biol. 2015 Mar;91(3):209-17. doi: 10.3109/09553002.2014.980466. Epub 2015 Jan 24.
3
Therapeutic radiation and the potential risk of second malignancies.
Cancer. 2016 Jun 15;122(12):1809-21. doi: 10.1002/cncr.29841. Epub 2016 Mar 7.
4
Radiation burden from secondary doses to patients undergoing radiation therapy with photons and light ions and radiation doses from imaging modalities.
Radiat Prot Dosimetry. 2014 Oct;161(1-4):357-62. doi: 10.1093/rpd/nct335. Epub 2013 Dec 18.
5
Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
J Radiol Prot. 2009 Jun;29(2A):A143-57. doi: 10.1088/0952-4746/29/2A/S10. Epub 2009 May 19.
6
Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence.
Cancer. 2003 May 15;97(10):2397-403. doi: 10.1002/cncr.11362.
7
Long-Term Risk of Skin Cancer Among Childhood Cancer Survivors: A DCOG-LATER Cohort Study.
J Natl Cancer Inst. 2019 Aug 1;111(8):845-853. doi: 10.1093/jnci/djy212.
8
Predicted rates of secondary malignancies from proton versus photon radiation therapy for stage I seminoma.
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):242-9. doi: 10.1016/j.ijrobp.2010.11.021. Epub 2011 Jan 13.
9
Special radiobiological features of second cancer risk after particle radiotherapy.
Phys Med. 2017 Oct;42:221-227. doi: 10.1016/j.ejmp.2017.05.002. Epub 2017 Nov 2.
10
Abscopal Effect: Propitious or Pernicious?
J Contemp Dent Pract. 2017 May 1;18(5):349-351.
引用本文的文献
1
Dose-volume histogram-based comparison of conventional and hypofractionated radiotherapy: lifetime attributable risk estimation in Indian breast carcinoma patients.
Radiol Phys Technol. 2025 Jun 14. doi: 10.1007/s12194-025-00924-z.
2
From survival of irradiated mice to modern molecular insights: a seventy-year journey in radiobiology at the institute of biophysics, Czech academy of sciences.
Eur Biophys J. 2025 Jun 13. doi: 10.1007/s00249-025-01765-9.
3
Management of Acquired Hypothalamic Obesity After Childhood-Onset Craniopharyngioma-A Narrative Review.
Biomedicines. 2025 Apr 22;13(5):1016. doi: 10.3390/biomedicines13051016.
4
Out-of-field neutron radiation from clinical proton, helium, carbon, and oxygen ion beams.
Med Phys. 2025 Jun;52(6):4924-4940. doi: 10.1002/mp.17797. Epub 2025 Apr 4.
5
Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas.
Oncologist. 2024 Dec 6;29(12):e1748-e1761. doi: 10.1093/oncolo/oyae195.
6
study of radiosensitivity in colorectal cancer cell lines associated with Lynch syndrome.
Front Public Health. 2024 Apr 4;12:1369201. doi: 10.3389/fpubh.2024.1369201. eCollection 2024.
7
Secondary neutron dosimetry for conformal FLASH proton therapy.
Med Phys. 2024 Jul;51(7):5081-5093. doi: 10.1002/mp.17050. Epub 2024 Apr 10.
8
The Pediatric Proton and Photon Therapy Comparison Cohort: Study Design for a Multicenter Retrospective Cohort to Investigate Subsequent Cancers After Pediatric Radiation Therapy.
Adv Radiat Oncol. 2023 May 21;8(6):101273. doi: 10.1016/j.adro.2023.101273. eCollection 2023 Nov-Dec.
9
In Vitro Models of Cell Senescence: A Systematic Review on Musculoskeletal Tissues and Cells.
Int J Mol Sci. 2023 Oct 26;24(21):15617. doi: 10.3390/ijms242115617.
10
High-LET charged particles: radiobiology and application for new approaches in radiotherapy.
Strahlenther Onkol. 2023 Dec;199(12):1225-1241. doi: 10.1007/s00066-023-02158-7. Epub 2023 Oct 23.
本文引用的文献
1
Kilovoltage imaging doses in the radiotherapy of pediatric cancer patients.
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1680-8. doi: 10.1016/j.ijrobp.2011.01.062. Epub 2011 Apr 7.
2
The risks to healthy tissues from the use of existing and emerging techniques for radiation therapy.
Radiat Prot Dosimetry. 2011 Feb;143(2-4):533-5. doi: 10.1093/rpd/ncq524. Epub 2011 Jan 2.
3
Long-term effects of radiation exposure among adult survivors of childhood cancer: results from the childhood cancer survivor study.
Radiat Res. 2010 Dec;174(6):840-50. doi: 10.1667/RR1903.1. Epub 2010 Sep 17.
4
Complexity of advanced radiation therapy necessitates multidisciplinary inquiry into dose reconstruction and risk assessment.
Phys Med Biol. 2010 Dec 7;55(23). doi: 10.1088/0031-9155/55/23/E01.
5
Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma.
Phys Med Biol. 2010 Dec 7;55(23):7055-65. doi: 10.1088/0031-9155/55/23/S07. Epub 2010 Nov 12.
6
Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.
Phys Med Biol. 2010 Dec 7;55(23):7009-23. doi: 10.1088/0031-9155/55/23/S04. Epub 2010 Nov 12.
7
Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation.
Phys Med Biol. 2010 Dec 7;55(23):7067-80. doi: 10.1088/0031-9155/55/23/S08. Epub 2010 Nov 12.
8
Differential effects of genes of the Rb1 signalling pathway on osteosarcoma incidence and latency in alpha-particle irradiated mice.
Radiat Environ Biophys. 2011 Mar;50(1):135-41. doi: 10.1007/s00411-010-0339-4. Epub 2010 Nov 10.
9
Does tumour dormancy offer a therapeutic target?
Nat Rev Cancer. 2010 Dec;10(12):871-7. doi: 10.1038/nrc2933. Epub 2010 Nov 4.
10
Cancer risks after radiation exposure in middle age.
J Natl Cancer Inst. 2010 Nov 3;102(21):1628-36. doi: 10.1093/jnci/djq346. Epub 2010 Oct 25.
Zotero 插件